product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
CD2AP Antibody
catalog :
2135
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 4a
Hu M, Azeloglu E, Ron A, Tran Ba K, Calizo R, Tavassoly I, et al. A biomimetic gelatin-based platform elicits a pro-differentiation effect on podocytes through mechanotransduction. Sci Rep. 2017;7:43934 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig s8
Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed publisher
Riley J, Malik A, Holohan C, Longley D. DED or alive: assembly and regulation of the death effector domain complexes. Cell Death Dis. 2015;6:e1866 pubmed publisher
Iglói Z, Kazlauskas A, Saksela K, Macdonald A, Mankouri J, Harris M. Hepatitis C virus NS5A protein blocks epidermal growth factor receptor degradation via a proline motif- dependent interaction. J Gen Virol. 2015;96:2133-44 pubmed publisher
product information
SKU :
2135S
Product-Name :
CD2AP Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Western blot
Product-Category :
Cytoskeletal Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
80
Host :
Rabbit
Target :
CD2AP
Primary-Protein :
CD2AP
Alt-Names :
Adapter protein CMS,CD2-associated protein,CD2AP,CMS,Cas ligand with multiple SH3 domains,Cas ligand with multiple Src homology 3 (SH3) domains,DKFZp586H0519
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.